VMQ StocksFor the value investor looking to harness academic research in
an actively managed portfolio
Bits and BipsNewsletter delivering insights on linking traditional finance, macro trends and cryptocurrency opportunities to help investors build stronger, more diversified portfolios.
All premium products come with free basic membership.
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Financial Summary
Share Statistics
ADGM
Industry Median
Percentile (All Stocks)
Market Cap (Mil)
$1.1
$370.8
1%
Shares Out (Mil)
0.8
41.4
4%
Institutional Ownership
89.0%
82.9%
56%
Float (Mil)
0.3
37.4
1%
Beta
na
0.89
na
Avg Daily Volume (000s)
213
323
45%
Price Change (52-week)
(93.4%)
57.7%
4%
Growth
ADGM
Industry Median
Percentile (All Stocks)
Sales (5yr)
na
11.8%
na
Net Income (5yr)
na
(5.7%)
na
EPS (5yr)
na
10.6%
na
Dividends (5yr)
na
0.0%
na
Cash Flow (5yr)
na
(15.8%)
na
Estimates
Qtrly
Current Fiscal Year
Next Fiscal Year
# of Estimates
1
1
1
Current EPS
($8.700)
($35.700)
($36.600)
Month Ago EPS
($7.800)
($32.700)
($34.800)
# Rev Up
0
1
1
# Rev Down
0
0
0
Three Months Ago EPS
($7.800)
($32.700)
($34.800)
Year/Year Chg
(140.6%)
(21.4%)
(11.4%)
Financials
ADGM
Industry Median
Percentile (All Stocks)
Sales (TTM) (Mil)
na
$125
na
Net Income (TTM) (Mil)
$1
($9)
39%
EPS (TTM)
$1.133
($0.300)
62%
Operating Cash Flow (TTM) (Mil)
($18)
($1)
16%
Net Cash Flow (TTM) (Mil)
na
$2
na
Long-Term Debt (Q1) (Mil)
$3
$21
21%
Enterprise Value (Q1) (Mil)
$2
$381
5%
Valuation
ADGM
Industry Median
Percentile (All Stocks)
P/B
0.07
2.52
2%
P/E
1.4
26.1
1%
Dividend Yield
na
0.0%
na
PEG (5yr hist)
na
1.3
na
Ratios
ADGM
Industry Median
Percentile (All Stocks)
Gross Margin
na
59.5%
na
Net Margin
na
(4.5%)
na
ROA
2.7%
(10.1%)
59%
ROE
9.6%
(8.5%)
55%
Liabilities to Assets
38.5%
45.8%
29%
F-Score
4
4
33%
Passing Stock Screens
As of 11/18/2026, from a list of 60 stock screening strategies,
ADGM meetings the criteria of 1 screen:
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors